Biop Medical Launches Cervical Cancer Diagnosis Technology at MEDICA 2017

November 13, 2017 — Biop Medical announced it will present its point-of-care cervical cancer detection technology at MEDICA 2017 in Düsseldorf, Germany, Nov. 13-16.  The company recently started its second round of investment.

The tool advances cervical cancer diagnosis using optic technology that accurately detects cancerous and pre-cancer lesions in real time. Patients receive an immediate diagnosis without the prolonged waiting time and stress associated with common diagnostic methods. The technology generates a map of diseased lesions to help physicians pinpoint exactly where to perform biopsies.

Biop Medical’s system consists of two components which are connected to the main control unit. The high definition Biop digital colposcope module offers a high-resolution digital cervix visualization. When the Biop micro-colposcope module is connected, it is directed by an algorithm to the centre of the cervix and then performs a thorough high-magnification inner scan of the cervix.

Using a sterile and disposable cover, the device is inserted until it is in contact with the cervix and projects a full array of light into the full depth of the cervix. The received refractions and reflections off the cervical tissue by the emitted light indicate where cancerous and pre-cancerous lesions are located. When used together, the scans from both components create a color map to help physicians determine where to perform biopsies.

This data can help track the cancer's advancement, with results automatically uploaded to the cloud. The platform for aggregating the data was developed with the support of IBM during Biop Medical's time at the IBM Alpha Zone Accelerator.

The technology requires a short and simple training, compared to years of experience required to capably perform cervical cancer diagnosis with a colposcope.

For more information: www.biopmedical.com